- Home
- KLXE vs MRNS Comparison
KLXE vs MRNS Comparison
Compare KLXE & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- MRNS
- Stock Information
- Founded
- KLXE 2018
- MRNS 2003
- Country
- KLXE United States
- MRNS United States
- Employees
- KLXE N/A
- MRNS N/A
- Industry
- KLXE Oilfield Services/Equipment
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- MRNS Health Care
- Exchange
- KLXE Nasdaq
- MRNS Nasdaq
- Market Cap
- KLXE 90.4M
- MRNS 104.7M
- IPO Year
- KLXE N/A
- MRNS 2014
- Fundamental
- Price
- KLXE $4.51
- MRNS $0.31
- Analyst Decision
- KLXE Hold
- MRNS Buy
- Analyst Count
- KLXE 1
- MRNS 12
- Target Price
- KLXE $4.50
- MRNS $4.56
- AVG Volume (30 Days)
- KLXE 92.5K
- MRNS 5.7M
- Earning Date
- KLXE 11-04-2024
- MRNS 11-05-2024
- Dividend Yield
- KLXE N/A
- MRNS N/A
- EPS Growth
- KLXE N/A
- MRNS N/A
- EPS
- KLXE N/A
- MRNS N/A
- Revenue
- KLXE $769,700,000.00
- MRNS $30,263,000.00
- Revenue This Year
- KLXE N/A
- MRNS $21.18
- Revenue Next Year
- KLXE $3.17
- MRNS $56.42
- P/E Ratio
- KLXE N/A
- MRNS N/A
- Revenue Growth
- KLXE N/A
- MRNS 16.56
- 52 Week Low
- KLXE $4.18
- MRNS $0.26
- 52 Week High
- KLXE $12.13
- MRNS $11.26
- Technical
- Relative Strength Index (RSI)
- KLXE 33.44
- MRNS 21.75
- Support Level
- KLXE $4.31
- MRNS $0.29
- Resistance Level
- KLXE $4.59
- MRNS $1.96
- Average True Range (ATR)
- KLXE 0.31
- MRNS 0.12
- MACD
- KLXE -0.05
- MRNS -0.18
- Stochastic Oscillator
- KLXE 8.92
- MRNS 2.41
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.